Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Nebraska

Phase 1 cancer trials in Nebraska

39 Phase 1 cancer studies are recruiting participants at sites in 2 cities across Nebraska as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Nebraska city with a recruiting study

By research area: Breast Cancer (9), Lung Cancer (9), Lymphoma (8), Prostate Cancer (8), Pancreatic Cancer (3), Melanoma (2).

Omaha (38), Grand Island (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Nebraska

Basic details from each study's public record (the 12 most recently updated of 39). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

    • Phase 1/2
    • All ages
    • All sexes
    Sponsor
    RayzeBio, Inc.
    Recruiting in
    Omaha
    Registry record
    NCT06590857 · updated
  2. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Omaha
    Registry record
    NCT03424005 · updated
  3. Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Omaha
    Registry record
    NCT07660055 · updated
  4. A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Terremoto Biosciences Inc.
    Recruiting in
    Omaha
    Registry record
    NCT07109726 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Nebraska on ClinicalTrials.gov.

Lung cancer: recently updated in Nebraska

  1. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Omaha
    Registry record
    NCT07277413 · updated
  2. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Omaha
    Registry record
    NCT03460977 · updated
  3. Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Recruiting in
    Omaha
    Registry record
    NCT04198766 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Nebraska on ClinicalTrials.gov.

Prostate cancer: recently updated in Nebraska

  1. RYZ711 Diagnostic Platform Study

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    RayzeBio, Inc.
    Recruiting in
    Omaha
    Registry record
    NCT07862582 · updated
  2. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Omaha
    Registry record
    NCT06800313 · updated
  3. A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Aktis Oncology, Inc.
    Recruiting in
    Omaha
    Registry record
    NCT07581184 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Nebraska on ClinicalTrials.gov.

Pancreatic cancer: recently updated in Nebraska

  1. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Recruiting in
    Omaha
    Registry record
    NCT06710756 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Nebraska on ClinicalTrials.gov.

Ask about studies in Nebraska

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call